Egis Commits to Voluntary Price Cap
Thu, Jun 12, 2025 11:31 AM
As a key player in the Hungarian pharmaceutical industry, Egis is voluntarily joining the initiative of the Ministry of National Economy aimed at curbing the price increases of Reparon Ointment 30g. More

Egis Pharmaceuticals PLC and the Faculty of Mechanical Engineering at BME Sign Cooperation Agreement

Following its successful collaboration with the Faculty of Chemical Technology and and Biotechnology at BME, Egis Pharmaceuticals PLC has now entered into a close professional partnership with the Faculty of Mechanical Engineering. The aim of the agreement is to support students’ practical training, enhance the development of competencies required in the labor market, nurture promising talent, and showcase the opportunities the pharmaceutical industry offers to young professionals with relevant technical qualifications.
Sep. 01.
More

Egis Invests Over HUF 14 Billion in Körmend Site Development

As part of its ongoing development program, Egis Pharmaceuticals PLC is investing over HUF 14 billion to expand its Körmend site. The project, supported by HUF 3.5 billion in government funding, will increase production capacities and modernise technological infrastructure, further strengthening the strategic importance of the facility.
Jul. 28.
More

Volunteer Day at Two Locations

Our colleagues participated in a dedicated, organized volunteer day.
Jun. 10.
More
Mar. 23.

Family-friendly workplace, family-friendly company

After being recognized as a Family-Friendly Workplace, we also received the title of Family-Friendly Company. Caring for others is an essential part of our century-long tradition.

More
Oct. 02.

Egis Attends Heart Day

Egis attended the event with a fork lift truck simulator that playfully presented the firm’s therapeutic areas.

More
Apr. 11.

Egis - One of the Most Attractive Workplaces in the Pharma Industry

According to the Randstad Employer Brand survey, employees would primarily like to join our company in the Hungarian pharmaceutical sector. Egis has won a special award for its outstanding result.

More
Feb. 06.

Egis strengthens presence in Russia by OTC acquisition

Hungarian-based Egis Pharmaceuticals acquired D-Panthenol and women’s health product portfolio from Jadran-Galenski Laboratorij’s (JGL). The company intends to further strengthen its position in major export markets, via select acquisitions.

More
Jan. 30.

Over 2 million vitamin capsules for families in need

Egis has donated 50,000 boxes of vitamin C capsules to Hungarian families coping with difficulties. The donations were taken by the Children’s Food Foundation to residents in underdeveloped regions under the “Pharmacy for the Poor” programme.

More
May. 12.

Active Agent Production Renewed

By renewing our active agent base, we wish to simultaneously raise the rate of our active agents produced internally in a reliable quality and at a competitive price as well as to increase our exports.

More
Mar. 18.

Over 1000 participants at the national PAD Day

The screening tests conducted in Budapest and at five rural venues - Debrecen, Győr, Miskolc, Pécs and Szeged - and combined with free medical consulting attracted more than 1000 visitors.

More

Submit
Submit

Cookie Settings

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

Cookies necessary for basic functioning

These cookies ensure the appropriate functioning of the website, facilitate its use and collect information on its use without identifying visitors.

Functional cookies

In order to enhance the user experience, we use cookies which record the use of certain functions of the website, thus enabling users to have the same settings at the time of their next visit.

Cookies for statistical purposes

They provide statistical data on the performance of the website (such as number of page loads, average time spent on the website) in order to collect data for the operator of the website on the website usage patterns of users. These cookies do not identify visitors, information collected by them relate to the number of subpages visited by the user, the length of each session, the types of error messages, etc. Cookies for statistical purposes are automatically placed on the user’s devices during browsing, and you can delete such cookies in the browser settings.
Details
I Agree
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox